Miragen Therapeutics – Consensus Indicates Potential 36.8% Upside

Broker Ratings

Miragen Therapeutics found using ticker (MGEN) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 44 and 18 and has a mean target at 31.5. Now with the previous closing price of 23.03 this is indicating there is a potential upside of 36.8%. The 50 day MA is 19.64 and the 200 moving average now moves to 16. The company has a market capitalisation of $90m. Find out more information at: 0

0

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Share on Stocktwits

Good news travels fast (but only if you make that happen). Share on:

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on reddit
Reddit

AIM All Share Index